IP Library Assignment 058957/0447
Patent Assignment
Reel/Frame 058957/0447

Security Interest

Recorded: 2021-12-10 Pages: 84
Assignors
MESOBLAST LIMITED ACN 109 431 870
Executed: 2021-11-19
MESOBLAST UK LIMITED
Executed: 2021-11-19
MESOBLAST INTERNATIONAL SÀRL
Executed: 2021-11-19
Assignee
OAKTREE FUND ADMINISTRATION, LLC
333 S. GRAND AVENUE, 28TH FLOOR, LOS ANGELES, CALIFORNIA, 90071
Covered Properties (78)
Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase
Application: 16/867,252 →
Publication: US US20200332023A1
Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof
Application: 17/369,147 →
Publication: US US20210355447A1
Treatment of Excessive Neovascularization
Application: 15/788,438 →
Publication: US US20180369286A1
Methods of Generating, Repairing and/or Maintaining Connective Tissue in Vivo
Application: 16/585,911 →
Publication: US US20200101118A1
Repair and/or Reconstitution of Invertebral Discs
Application: 14/504,308 →
Publication: US US20150044186A1
Production of Reprogrammed Pluripotent Cells
Application: 15/299,088 →
Publication: US US20170037377A1
Method of Treating Graft Versus Host Disease
Application: 17/077,698 →
Publication: US US20210085723A1
Methods of Treating or Preventing Neurological Diseases
Application: 17/177,065 →
Publication: US US20210169940A1
Method of Treating the Effects of Stroke
Application: 17/194,855 →
Publication: US US20210228639A1
Methods of Treating or Preventing Respiratory Conditions
Application: 16/889,354 →
Publication: US US20200289578A1
Treatment of Diseases of Endothelial Dysfunction and Inflammation
Application: 14/650,172 →
Publication: US US20160175360A1
Stem Cell Composition
Application: 16/434,726 →
Publication: US US20190345452A1
Treatment of Immune Disorders
Application: 16/828,121 →
Publication: US US20200281984A1
Method for Treating Heart Failure
Application: 15/534,371 →
Publication: US US20170333482A1
Prevention of Progressive Heart Failure
Application: 15/534,376 →
Publication: US US20170340674A1
Cell Culture Method for Mesenchymal Stem Cells
Application: 16/599,271 →
Publication: US US20200040303A1
Potency Assay
Application: 15/571,178 →
Publication: US US20200140822A1
Methods and Apparatus for Separating Cells from Microcarriers
Application: 15/575,160 →
Publication: US US20180142201A1
Mesenchymal Lineage Precursor or Stem Cells with Enhanced Immunosuppression
Application: 16/607,293 →
Publication: US US20200325450A1
Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer
Application: 16/766,206 →
Publication: US US20210163932A1
Expansion of Hematopoietic Stem Cells
Application: 17/286,972 →
Publication: US US20210388319A1
Method for Treating Lower Back Pain
Application: 17/420,314 →
Publication: US US20220143097A1
Method for Improving Visual Acuity
Application: 17/420,325 →
Publication: US US20220079991A1
Method for Treating or Preventing Gastrointestinal Bleeding
Application: 17/425,893 →
Publication: US US20220160776A1
Mesenchymal Stem Cells and Uses Therefor
Application: 16/214,485 →
Publication: US US20190240259A1
Mesenchymal Stem Cells Expressing TNF-alpha Receptors
Application: 17/087,124 →
Publication: US US20210171913A1
Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
Application: 16/694,382 →
Publication: US US20200197444A1
Enhanced Msc Preparations
Application: 16/725,677 →
Publication: US US20200231936A1
Mesenchymal Precursor Cell
Patent: 7,122,178 →
Application: 10/030,411 →
Mesenchymal Precursor Cell
Patent: 7,670,628 →
Application: 10/813,747 →
Publication: US US20050019911A1
Mesenchymal Precursor Cell
Patent: 8,158,118 →
Application: 11/169,875 →
Publication: US US20050281790A1
Perivascular Mesenchymal Precursor Cells
Patent: 7,947,266 →
Application: 10/551,162 →
Publication: US US20070065938A1
Perivascular Mesenchymal Precursor Cells
Application: 14/746,960 →
Publication: US US20170204373A9
Method of Increasing Proliferation of Bone Marrow Mononuclear Cells Expressing STRO1-Dim
Application: 14/470,769 →
Publication: US US20150072422A1
Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase
Patent: 8,367,405 →
Application: 11/918,593 →
Publication: US US20090074728A1
Isolation of Adult Multipotential Cells by Tissue Non-Specific Alkaline Phosphatase
Patent: 9,783,617 →
Application: 15/167,934 →
Publication: US US20160264683A1
Perivascular Mesenchymal Precursor Cell Induced Blood Vessel Formation
Patent: 9,169,466 →
Application: 10/551,326 →
Publication: US US20060286077A1
Perivascular mesenchymal precursor cell induced blood vessel formation
Patent: 9,175,267 →
Application: 11/326,736 →
Publication: US US20060193840A1
Methods of Generating, Repairing and/or Maintaining Connective Tissue in Vivo
Patent: 9,381,216 →
Application: 12/452,767 →
Publication: US US20100203020A1
Repair and/or Reconstitution of Invertebral Discs
Patent: 8,858,932 →
Application: 13/000,721 →
Publication: US US20110189138A1
Expansion of Haemopoietic Precursors
Patent: 8,828,375 →
Application: 13/061,693 →
Publication: US US20110217263A1
Expansion of Haemopoietic Precursors
Patent: 9,415,072 →
Application: 14/476,467 →
Publication: US US20150202232A1
Monoclonal Antibody Stro-4
Patent: 9,090,678 →
Application: 13/059,448 →
Publication: US US20110189696A1
Monoclonal Antibody Stro-4
Patent: 9,815,896 →
Application: 14/795,449 →
Publication: US US20150307608A1
Method for Treating or Preventing a Pancreatic Dysfunction
Patent: 8,894,972 →
Application: 13/129,180 →
Publication: US US20110243902A1
Method for Treating Diabetic Renal Failure or Syndrome X
Patent: 9,480,713 →
Application: 14/535,827 →
Publication: US US20150064148A1
Method for Treating or Preventing a Pancreatic Dysfunction
Patent: 9,968,640 →
Application: 15/336,234 →
Publication: US US20170042945A1
Production of Reprogrammed Pluripotent Cells
Patent: 9,487,756 →
Application: 13/257,233 →
Publication: US US20120121548A1
Method of Treating Graft Versus Host Disease
Patent: 9,301,978 →
Application: 13/808,093 →
Publication: US US20130171113A1
Method of Treating Graft Versus Host Disease
Application: 15/055,221 →
Publication: US US20160361363A1
Method of Treating Graft Versus Host Disease
Application: 16/131,975 →
Publication: US US20190030080A1
Methods of Treating or Preventing Rheumatic Disease
Patent: 9,265,796 →
Application: 14/130,647 →
Publication: US US20140271567A1
Methods of Treating or Preventing Rheumatic Disease
Patent: 9,974,812 →
Application: 14/992,487 →
Publication: US US20160199415A1
Methods of Treating or Preventing Rheumatic Disease
Application: 15/954,768 →
Publication: US US20180303879A1
Methods for Treating Obesity and/or Metabolic Syndrome
Patent: 9,388,385 →
Application: 14/118,862 →
Publication: US US20140294775A1
Methods for Treating Obesity and/or Metabolic Syndrome
Application: 15/176,741 →
Publication: US US20170119822A1
Methods of Treating Multiple Sclerosis Using Stro-1+ and Tnap+ Multipotential Cells
Application: 14/123,758 →
Publication: US US20140322276A1
Methods for Increasing Osteoblastic Function
Patent: 9,642,878 →
Application: 14/343,730 →
Publication: US US20140363404A1
Methods for Increasing Osteoblastic Function
Application: 16/460,734 →
Publication: US US20190343887A1
Methods of Treating or Preventing Respiratory Conditions
Application: 14/650,171 →
Publication: US US20150306146A1
Methods of Treating or Preventing Respiratory Conditions
Application: 16/036,402 →
Publication: US US20190046575A1
Improved Stem Cell Composition
Application: 15/300,716 →
Publication: US US20170107495A1
Treatment of Immune Disorders
Application: 15/317,673 →
Publication: US US20170106023A1
Mesenchymal Stem Cells and Uses Therefor
Patent: 9,943,547 →
Application: 14/087,830 →
Publication: US US20140154276A1
Mesenchymal Stem Cells and Uses Therefor
Patent: 9,694,035 →
Application: 14/334,128 →
Publication: US US20150017132A1
Mesenchymal Stem Cells and Uses Therefor
Application: 14/138,577 →
Publication: US US20140161776A1
Mesenchymal Stem Cells and Uses Therefor
Application: 16/204,936 →
Publication: US US20190175657A1
Mesenchymal Stem Cells and Uses Therefor
Application: 16/206,235 →
Publication: US US20190201447A1
Mesenchymal Stem Cells and Uses Therefor
Application: 16/811,900 →
Publication: US US20200246387A1
Mesenchymal Stem Cells and Uses Therefor
Application: 16/815,784 →
Publication: US US20200360442A1
Mesenchymal Stem Cells Expressing TNF-alpha Receptors
Patent: 8,486,695 →
Application: 13/402,498 →
Publication: US US20120214178A1
Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
Patent: 8,637,004 →
Application: 12/541,282 →
Publication: US US20100068191A1
Enhanced Msc Preparations
Patent: 9,828,586 →
Application: 14/138,265 →
Publication: US US20140112893A1
Enhanced Msc Preparations
Patent: 9,963,678 →
Application: 14/662,344 →
Publication: US US20150247122A1
Enhanced Msc Preparation
Application: 15/945,148 →
Publication: US US20180291347A1
Protease-Resistant Mutants of Stromal Cell Derived Factor-1 in the Repair of Tissue Damage
Patent: 9,308,277 →
Application: 13/029,891 →
Publication: US US20110224139A1
Protease-Resistant Mutants of Stromal Cell Derived Factor-1 in the Repair of Tissue Damage
Application: 15/054,456 →
Publication: US US20160375100A1
Methods for Repairing Tissue Damage Using Protease-Resistant Mutants of Stromal Cell Derived Factor-1
Application: 14/124,187 →
Publication: US US20140199304A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name May 10, 2012
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 028192/0789 →
Assignment of Assignor's Interest Oct 27, 2017
From: RAKOCZY, PIROSKA ELIZABETH
To: VISOGENE PTY LTD
Reel/Frame 043970/0856 →
Assignment of Assignor's Interest Oct 30, 2017
From: VISOGENE PTY LTD
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 043984/0157 →
Change of Name Oct 31, 2017
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 044637/0898 →
Assignment of Assignor's Interest Nov 16, 2017
From: ITESCU, SILVIU; GOLDEN, LEE
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 044152/0863 →
Assignment of Assignor's Interest Nov 21, 2017
From: ITESCU, SILVIU; GOLDEN, LEE
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 044191/0482 →
Assignment of Assignor's Interest Dec 15, 2017
From: DAVIDZON, NORMAND; SIMMONS, PAUL
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 044408/0499 →
Assignment of Assignor's Interest Dec 15, 2017
From: SIMMONS, PAUL; SUIRE, COLBY; SEE, FIONA
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 044408/0566 →
Intellectual Property Security Agreement Mar 28, 2018
From: MESOBLAST INTERNATIONAL SARL
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0917 →
Intellectual Property Security Agreement Mar 28, 2018
From: MESOBLAST, INC.
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0682 →
Assignment of Assignor's Interest Jun 10, 2019
From: ITESCU, SILVIU; SIMMONS, PAUL
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 049420/0740 →
Assignment of Assignor's Interest Sep 30, 2019
From: GHOSH, PETER
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 050565/0378 →
Change of Name Sep 30, 2019
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 050583/0751 →
Assignment of Assignor's Interest Oct 15, 2019
From: SIMMONS, PAUL; SUIRE, COLBY
To: MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 050719/0520 →
Assignment of Assignor's Interest Feb 6, 2020
From: ITESCU, SILVIU; SIMMONS, PAUL
To: MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 051740/0220 →
Assignment of Assignor's Interest Mar 31, 2020
From: ITESCU, SILVIU; SIMMONS, PAUL
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 052270/0385 →
Change of Name May 14, 2020
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 052672/0900 →
Assignment of Assignor's Interest May 14, 2020
From: GRONTHOS, STAN; ZANNETTINO, ANDREW CHRISTOPHER WILLIAM; SIMMONS, PAUL JOHN
To: MESOBLAST, INC.
Reel/Frame 052667/0167 →
Assignment of Assignor's Interest Jun 2, 2020
From: ITESCU, SILVIU; KRISHNAN, RAVI; GHOSH, PETER
To: MESOBLAST, INC.
Reel/Frame 052810/0768 →
Assignment of Assignor's Interest Oct 23, 2020
From: ITESCU, SILVIU; SCHUSTER, MICHAEL DAVID
To: MESOBLAST, INC.
Reel/Frame 054152/0438 →
Assignment of Assignor's Interest Feb 18, 2021
From: BERNARD, CLAUDE
To: MESOBLAST, INC.
Reel/Frame 055322/0111 →
Assignment of Assignor's Interest Jul 9, 2021
From: GRONTHOS, STAN; ZANNETTINO, ANDREW CHRISTOPHER WILLIAM
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 056805/0297 →
Change of Name Jul 9, 2021
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 056819/0765 →
Release of Intellectual Property Security Agreement at Reel/Frame No. 45759/0682 Jul 30, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: MESOBLAST, INC.
Reel/Frame 072294/0555 →
Release of Intellectual Property Security Agreement at Reel/Frame No. 45759/0917 Jul 30, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 072297/0753 →